3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
23
Breast Neoplasms
12
Prostatic Neoplasms
11
Triple Negative Breast Neoplasms
7
Fallopian Tube Neoplasms
7
Stomach Neoplasms
5
Neoplasm Metastasis
5
Sarcoma
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Metastatic Castration-resistant Prostate Cancer
4
Fanconi Anemia, Complementation Group D1
4
Small Cell Lung Carcinoma
3
Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Wilms Tumor
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Endometrial Neoplasms
2
Interventions
Ipilimumab
6
pembrolizumab
5
Nivolumab
5
Dacarbazine
5
CTLA-4 Antigen
4
Carboplatin
3
Bevacizumab
3
relatlimab
2
aflibercept
2
Temozolomide
2
Ranibizumab
2
Radiosurgery
2
Paclitaxel
2
Lenalidomide
2
Immunoglobulin G
2
Embolization, Therapeutic
2
Disulfides
2
Cyclophosphamide
2
Colony-Stimulating Factors
2
Albumin-Bound Paclitaxel
2
AZD 6244
2
130-nm albumin-bound paclitaxel
2
utomilumab
1
ulixertinib
1
trametinib
1
tebentafusp
1
sotrastaurin
1
sargramostim
1
poly ICLC
1
pasireotide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Uveal Melanoma
×
olaparib
×
Clear all
No trials found.